Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The effectiveness of maternal immunization in preventing infant pertussis was first demonstrated in England, 1 year after the program using diphtheria-tetanus-5-component acellular pertussis-inactivated polio vaccine (dT5aP-IPV) was introduced in 2012. Vaccine effectiveness against laboratory-confirmed pertussis has been sustained >90% in the 3 years following its introduction, despite changing to another acellular vaccine with different antigen composition. Consistent with this, disease incidence in infants <3 months of age has remained low despite high activity persisting in those aged 1 year and older. Vaccine effectiveness against infant deaths was estimated at 95% (95% confidence interval, 79%-100%). Additional protection from maternal immunization is retained in infants who received their first dose of the primary series. There is no longer evidence of additional protection from maternal vaccination after the third infant dose. Although numbers are small and ongoing assessment is required, there is no evidence of increased risk of disease after primary immunization in infants whose mothers received maternal vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Maternal vaccination with a pertussis-containing vaccine is now routinely recommended in several countries and has been shown to be safe and to result in high concentrations of antibody in the infant over the first 2 months of life (18–21).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of maternal pertussis vaccination in England: an observational study
Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., & Ramsay, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60686-3 · Cited by 739 · cited 6×
“matched to the general practice of the cases [10, 11].”
BackgroundMethodInfluentialSelf-citationSawyer, M., Liang, J. L., Messonnier, N. E., & Clark, T. A. (2013) · MMWR Morbidity and Mortality Weekly Report · Cited by 722
Munoz, F. M., Bond, N. H., Maccato, M., Pinell, P., Hammill, H. A., Swamy, G. K., Walter, E. B., Jackson, L. A., Englund, J. A., Edwards, M. S., et al. (2014) · JAMA · doi:10.1001/jama.2014.3633 · Cited by 489
Dabrera, G., Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Fry, N. K., & Ramsay, M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu821 · Cited by 385 · cited 3×
“ceived vaccine at least 1 week prior to delivery, using both the screening method and case-control study approaches [10, 11], and this level of protection appears to have been sustained in the 3 years following the introduction of the program despite”
BackgroundMethodSelf-citationSafety of pertussis vaccination in pregnant women in UK: observational study
Donegan, K., King, B., & Bryan, P. (2014) · BMJ · doi:10.1136/bmj.g4219 · Cited by 281 · cited 1×
“servational study in the United Kingdom, which did not identify an increased risk for a range of maternal, fetal, and neonatal outcomes among almost 18 000 vaccinated pregnant women and their infants [12].”
BackgroundEstimation of Vaccine Effectiveness Using the Screening Method
FARRINGTON, C. P. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.4.742 · Cited by 261 · cited 1×
“Detailed methods have been previously described [10, 19].”
Eberhardt, C. S., Blanchard-Rohner, G., Lemaître, B., Boukrid, M., Combescure, C., Othenin-Girard, V., Chilin, A., Petre, J., de Tejada, B. M., & Siegrist, C.-A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw027 · Cited by 253
Bogoch, I. I., Creatore, M. I., Cetron, M. S., Brownstein, J. S., Pesik, N., Miniota, J., Tam, T., Hu, W., Nicolucci, A., Ahmed, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61828-6 · Cited by 235
Research works printed but not linked: 1
- Maertens, 2015, Pertussis vaccination of pregnant women: rationale for the actual recommendations in Belgium, Tijdschrift Voor Geneeskunde, 71, 497
Cited by
Items 101–200 of 287
Health Outcomes in Young Children Following Pertussis Vaccination During Pregnancy
Laverty, M., Crowcroft, N. S., Bolotin, S., Hawken, S., Wilson, K. R., Amirthalingam, G., Biringer, A. B., Cook, J. L., Dubey, V., Fakhraei, R., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2020-042507 · Cited by 20
Self-citationPertussis epidemiology in Argentina: TRENDS after the introduction of maternal immunisation
Fabricius, G., Aispuro, P. M., Bergero, P. E., Bottero, D., Gabrielli, M., & Hozbor, D. F. (2018) · Epidemiology and Infection · doi:10.1017/s0950268818000808 · Cited by 20
“The finding from England was that in the 3 years following the introduction of an MI programme, vaccine effectiveness against confirmed pertussis had been sustained over 90% [19].”
InfluentialProtection of the Newborn Through Vaccination in Pregnancy
Abu-Raya, B., & Maertens, K. (2021) · NeoReviews · doi:10.1542/neo.22-1-e25 · Cited by 20
Effectiveness of maternal pertussis vaccination in protecting newborn: A matched case-control study
Godoy, P., Cenoz, M. G., Rius, C., Muñoz‐Almagro, C., Carmona, G., Alsedà, M., Jané, M., Vidal, M.-J., Rodríguez, R., Álvarez, J., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.08.022 · Cited by 20
Abu-Raya, B., Maertens, K., Muñoz, F. M., Zimmermann, P., Curtis, N. C., Halperin, S. A., Rots, N. Y., Barug, D., Holder, B. S., Rice, T. F., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.09.022 · Cited by 23
Sandmann, F., Jit, M., Andrews, N. J., Buckley, H., Campbell, H., Ribeiro, S., Sile, B., Stowe, J., Tessier, E., Ramsay, M. E., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa165 · Cited by 22
“Immunisation agreed to continue the maternal program for a further 5 years, with a decision to be made in 2019 about whether to maintain it as a routine program [1].”
BackgroundSelf-citationImmunisation schedule of the Spanish Association of Paediatrics: 2019 recommendations
Moreno‐Pérez, D., García, F. J. Á., Aldeán, J. Á., Ortega, M. J. C., Garcés‐Sánchez, M., Sánchez, N. G., Merino, Á. H., Hernández, M. J. M., Moína, M. M., Melián, A. M., et al. (2019) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2018.11.001 · Cited by 18
Widdershoven, V., Reijs, R. P., Eskes, A., Verhaegh-Haasnoot, A., & Hoebe, C. J. P. A. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05505-9 · Cited by 18
Tessier, E., Newport, D., Tran, A., Nash, S., Mensah, A. A., Wang, T. Y., Shantikumar, S., Campbell, H., Amirthalingam, G., & Todkill, D. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.08.073 · Cited by 18
“A study in Australia found no significant difference, while a study in England showed some declines in effectiveness following maternal and primary vaccinations, but there were few observations in both studies [26,67].”
InfluentialSelf-citationFortuna, L., Chaithongwongwatthana, S., Soonthornworasiri, N., Spiegel, J., Wijagkanalan, W., Mansouri, S., van den Biggelaar, A. H. J., & Pham, H. T. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.10.070 · Cited by 18
Factors That Influence Infant Immunity and Vaccine Responses
Zimmermann, P., & Jones, C. E. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002773 · Cited by 19
“However, data from the United Kingdom suggests that the reduction in pertussis-specific IgG is not associated with an excess of pertussis disease following primary immunization in infants born to vaccinated compared with unvaccinated women.(115) Most vaccines induce high antibody responses and small differences in ant…”
BackgroundPertussis vaccination in pregnancy: State of the art
Leuridan, E. E. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.061 · Cited by 18
Cost-effectiveness analysis of pertussis vaccination during pregnancy in Japan
Hoshi, S., Seposo, X., Okubo, I., & Kondo, M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.07.026 · Cited by 21
Khodr, Z. G., Bukowinski, A. T., Gumbs, G. R., & Conlin, A. M. S. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.041 · Cited by 20
The problem of pertussis in some regions of the world
Basov, A. A., Tsvirkun, O. V., Герасимова, А. Г., & Zekoreeva, A. K. (2019) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2019-2-354-362 · Cited by 21
de Barros, E. N. C., Nunes, A. A., de Abreu, A. D. J. L., Furtado, B. E., Cintra, O. A. L., Cintra, M. A. C. T., & Coelho, E. B. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1634991 · Cited by 18
Havers, F. P., Skoff, T. H., Rench, M. A., Epperson, M., Rajam, G., Schiffer, J. M., Hariri, S., Swaim, L. S., Baker, C. J., & Healy, C. M. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac432 · Cited by 19
Hutchinson, A. F., & Smith, S. M. S. (2020) · Midwifery · doi:10.1016/j.midw.2020.102734 · Cited by 16
Areta, M. L., Valiton, A., Diana, A., Morales, M., Wiederrecht-Gasser, J., Jacob, S., Chilin, A., Quarta, S., Jaksic, C., Vallarta-Robledo, J., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.04.076 · Cited by 16
“Vaccine effectiveness (VE) for antenatal pertussis immunization is 91–95% [15,16], with maximum neonatal protection obtained when the vaccine is done during 2nd versus 3rd trimester [17,18].”
BackgroundPetousis‐Harris, H., Jiang, Y., Yu, L. H., Watson, D. G., Walls, T., Turner, N. M., Howe, A. S., & Griffin, J. (2019) · Vaccines · doi:10.3390/vaccines7040147 · Cited by 17
Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2019
Moreno‐Pérez, D., García, F. J. Á., Aldeán, J. Á., Ortega, M. J. C., Garcés‐Sánchez, M., Sánchez, N. G., Merino, Á. H., Hernández, M. J. M., Moína, M. M., Melián, A. M., et al. (2019) · Anales de Pediatría · doi:10.1016/j.anpedi.2018.10.006 · Cited by 17
“(8) Vacuna frente a la varicela (Var).”
Barug, D., Berbers, G. A. M., van Houten, M. A., Kuijer, M., Pronk, I., Knol, M. J., Sanders, E. A. M., & Rots, N. Y. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.04.001 · Cited by 15
Impact of Helminth Infections during Pregnancy on Vaccine Immunogenicity in Gabonese Infants
Flügge, J., Adégnika, A. A., Honkpéhèdji, Y. J., Sandri, T. L., Askani, E., Manouana, G. P., Loembé, M. M., Brückner, S., Duali, M., Strunk, J., et al. (2020) · Vaccines · doi:10.3390/vaccines8030381 · Cited by 15
Martinón‐Torres, F., Halperin, S. A., Nolan, T. M., Tapiéro, B., Perrett, K. P., de la Cueva, I. S., García-Sicilia, J., Straňák, Z., Vanderkooi, O. G., Kosina, P., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.02.001 · Cited by 16
Burden of pertussis among young infants in Malaysia: A hospital-based surveillance study
Mohamed, T. J., Fong, S. M., Nadarajaw, T., Choo, C. M., Yusoff, N. K. N., Nachiappan, J. P., Chan, K. C., Koh, M.-Y., Amran, F. B., Hashim, R., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.07.019 · Cited by 14
Areta, M. L., Eberhardt, C. S., Siegrist, C., & de Tejada, B. M. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1406475 · Cited by 14
Wilcox, C. R., Woodward, C., Rowe, R., & Jones, C. E. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1640558 · Cited by 14
“Antenatal vaccination against pertussis was first introduced in the United Kingdom (UK) and United States (US) in 2012, following national outbreaks of pertussis.(4) Similar trends have”
BackgroundInfluentialLeong, H. N., Chiu, C., Heo, J. Y., Ip, M., Jung, K., Menzies, R., Pearce, R., Buchy, P., Chen, J., Nissen, M. D., et al. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1990759 · Cited by 14
“Maternal pertussis immunization programs are highly effective in addressing this need [14].”
BackgroundImpact of Maternal Pertussis Antibodies on the Infants’ Cellular Immune Responses
Orije, M. R. P., Garcia-Fogeda, I., Dyck, W. V., Corbière, V., Mascart, F., Mahieu, L. M., Hens, N., Damme, P. V., Cools, N., Ogunjimi, B., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab972 · Cited by 15
Meningococcal vaccination in pregnancy
Raya, B. A., & Sadarangani, M. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1445447 · Cited by 15
Clinical Findings and Management of Pertussis
Polinori, I., & Esposito, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_410 · Cited by 14
Pertussis in Italy: how to protect the “unprotectable”?
Fiasca, F., Necozione, S., & Mattei, A. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1806673 · Cited by 14
Rice, T. F., Diavatopoulos, D. A., Guo, Y., Donaldson, B., Bouqueau, M., Bosanquet, A., Barnett, S. M., Holder, B. S., & Kampmann, B. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103612 · Cited by 16
Chokephaibulkit, K., Puthanakit, T., Bhat, N., Mansouri, S., Tang, Y., Lapphra, K., Rungmaitree, S., Anugulruengkitt, S., Jantarabenjakul, W., Andi-Lolo, I., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.10.076 · Cited by 13
“Following evidence from the UK program that vaccination of pregnant women with pertussis vaccines is highly effective in preventing infant pertussis [8,9], an increasing number of HICs have introduced maternal pertussis vaccination into their national immunization programs.”
MethodInfluentialDuda-Madej, A., Łabaz, J. P., Topola, E., Bazan, H., & Viscardi, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199607 · Cited by 14
Prenatal tetanus-diphtheria-acellular pertussis vaccine effectiveness at preventing infant pertussis
Vargas-Zambrano, J. C., Clark, L. R., Johnson, D. R., Monfredo, C., Pool, V., Li, L., Bouvet, P.-E., Blangero, Y., & Macina, D. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.03.048 · Cited by 14
Muñoz, F. M., Damme, P. V., Dinleyici, E. Ç., Clarke, E., Kampmann, B., Heath, P. T., Levy, O., Leuridan, E. E., Cutland, C., Meulen, A. S.-T., et al. (2018) · mSphere · doi:10.1128/msphere.00221-18 · Cited by 13
“Over 90% vaccine effectiveness has been demonstrated consistently since introduction (23).”
BackgroundResultDeveloping product label information to support evidence-informed use of vaccines in pregnancy
Manca, T., Graham, J., Dubé, È., Kervin, M. S., Castillo, E., Crowcroft, N. S., Fell, D. B., Hadskis, M. R., Mannerfeldt, J., Greyson, D. L., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.063 · Cited by 13
Saso, A., Kanteh, E., Jeffries, D. J., Okoye, M. E., Mohammed, N. I., Kumado, M., Roetynck, S., Jobe, H., Faal, A., Roberts, E., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00072-6 · Cited by 12
Mott, K., Huybrechts, K. F., Glynn, R. J., Mogun, H., & Hernández–Díaz, S. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003099 · Cited by 12
“47,49 While still very informative, this is a different approach than the direct cohort comparison with covariate adjustment conducted here.”
ResultCurrent status of pertussis vaccination during pregnancy and influencing factors in Korea
Kim, C., Pae, J., Kim, W. J., Jang, Y.-R., Wie, J. H., Park, I. Y., & Ko, H. S. (2021) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2020.12.007 · Cited by 13
de Lima, L. R. A. V., Sato, A. P. S., Pawloski, L. C., Fernandes, É. G., Rajam, G., Sato, H. K., Patel, D., Li, H., de Castilho, E. A., Tondella, M. L., et al. (2021) · Vaccine X · doi:10.1016/j.jvacx.2021.100087 · Cited by 14
“Blunting, an inhibition of antibody response, has been previously observed [17–26] but its clinical relevance is still unknown [13,27,28].”
BackgroundResultPertussis Infections Among Pregnant Women in the United States, 2012–2017
Skoff, T. H., Faulkner, A. E., Liang, J. L., Barnes, M., Kudish, K. S., Thomas, E. S., Kenyon, C., Hoffman, M. R., Pradhan, E., Liko, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1112 · Cited by 14
Bayliss, J., Nissen, M. D., Prakash, D., Richmond, P., Oh, K.-B., & Nolan, T. M. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1764826 · Cited by 12
“The impact of maternal vaccination in reducing early pertussis notifications has been demonstrated both in Australia(96) and overseas.(97,98) This is further evidenced when NNDSS data are stratified according to the eligible num-”
BackgroundGiles, M., Kong, K. L., Krishnaswamy, S., Bellamy, K., Angliss, M., Smith, C. J., Fay, O., Paddle, P. M., & Vollenhoven, B. J. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04248-9 · Cited by 12
“Likewise in countries recommending pertussis vaccination during pregnancy, vaccine coverage has ranged between 44% in the United Kingdom to 78% in New Zealand [14, 15].”
BackgroundSapuan, S., Andrews, N. J., Hallis, B., Hole, L., Jones, C. E., Matheson, M., Miller, E., Snape, M. D., & Heath, P. T. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.10.005 · Cited by 13
“High vaccine effectiveness has been observed for both vaccines [2,6].”
InfluentialSelf-citationAbu-Raya, B., Esser, M. J., Nakabembe, E., Reiné, J., Amaral, K., Diks, A. M., Imede, E., Way, S. S., Harandi, A. M., GORRINGE, A. R., et al. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168344 · Cited by 12
Prevention of pertussis: from clinical trials to Real World Evidence
Esposito, S. (2018) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2018.59.3.1041 · Cited by 11
“the direct and specific efficacy of a single vaccine in preventing P in a given clinical trial [63-75].”
BackgroundSompagdee, N., Anuwutnavin, S., Phongsamart, W., Senawong, S., Umrod, P., & Robkhonburi, A. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.01.074 · Cited by 11
do Nascimento, R. M., Baptista, P. N., Lopes, K. A. D. M., Pimentel, A. M., Cruz, F. D. S. P., & Ximenes, R. A. D. A. (2021) · Jornal de Pediatria · doi:10.1016/j.jped.2020.10.018 · Cited by 12
Wolter, N., Cohen, C., Tempia, S., Walaza, S., Moosa, F., du Plessis, M., McMorrow, M., Treurnicht, F. K., Hellferscee, O., Dawood, H., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab089 · Cited by 11
Fakhraei, R., Fung, S. G., Petrcich, W., Crowcroft, N. S., Bolotin, S., Gaudet, L., Amirthalingam, G., Biringer, A. B., Wilson, K. R., Dubey, V., et al. (2022) · CMAJ Open · doi:10.9778/cmajo.20220058 · Cited by 11
Self-citationPertussis deaths in New Zealand without community transmission—an infant immunity gap?
McIntyre, P. B., Best, E., Byrnes, C. A., Sinclair, O., Trenholme, A. A., & Grant, C. C. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100850 · Cited by 10
Krishnaswamy, S., Wallace, E. M., Cheng, A. C., Buttery, J. P., & Giles, M. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.07.031 · Cited by 10
Risk Markers for Pertussis Among Infants <4 Months of Age: Understanding the Hispanic Disparity
Winter, K., & Harriman, K. H. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001707 · Cited by 10
Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?
Bellinghen, L.-A. V., Dimitroff, A., Haberl, M., Li, X., Manton, A., Moeremans, K., & Demarteau, N. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1474315 · Cited by 11
Pradhan, S. R., Mahata, S., Ghosh, D., Sahoo, P. K., Sarkar, S., Pal, R., & Nasare, V. D. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90197 · Cited by 13
Bosch, J., Fernández, H., Polak, F. P., Musante, G., Libster, R., & Rivarola, M. R. (2017) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2017.eng.311 · Cited by 11
Botwright, S., Win, E. M., Kapol, N., Benjawan, S., & Teerawattananon, Y. (2022) · PharmacoEconomics · doi:10.1007/s40273-022-01207-w · Cited by 9
“Two of the studies [52, 53] were assessed to be at serious risk of bias by one of the systematic reviews due to use of the screening method [50].”
MethodMaternal pertussis vaccination behavior: Psychosocial, attitudinal and organizational factors
Widdershoven, V., Reijs, R. P., Eskes, A., Verhaegh-Haasnoot, A., & Hoebe, C. J. P. A. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.11.013 · Cited by 9
Pertussis vaccination in pregnancy — current data on safety and effectiveness
Zasztowt‐Sternicka, M., Jagielska, A. M., & Nitsch-Osuch, A. S. (2021) · Ginekologia Polska · doi:10.5603/gp.a2021.0145 · Cited by 9
Core pertussis transmission groups in England and Wales: A tale of two eras
Bento, A. I., Riolo, M. A., Choi, Y. H., King, A. A., & Rohani, P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.046 · Cited by 9
“However, a national pertussis outbreak was announced in April 2012, despite high vaccine coverage [4,8–11], characterized not only by increased incidence but also a spate of pertussisrelated infant deaths [8,10,12].”
Desai, S. N., Schanzer, D. L., Silva, A., Rotondo, J., & Squires, S. G. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.10.047 · Cited by 10
Sandmann, F., Jit, M., Andrews, N. J., Buckley, H., Campbell, H., Ribeiro, S., Sile, B., Stowe, J., Tessier, E., Ramsay, M. E., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.06.042 · Cited by 9
Self-citationMaternal immunization: trends in South and Southeast Asian countries
Kamath, G. D., Kukreja, S., Mukherjee, P., Kolhapure, S., & Sathyanarayanan, S. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1974389 · Cited by 9
Vaccine‐preventable child deaths in New South Wales from 2005 to 2014: How much is preventable?
Phillips, A., Beard, F., Macartney, K. K., Chan, J., Gilmour, R. E., Saravanos, G. L., & McIntyre, P. B. (2018) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.13835 · Cited by 10
Embacher, S., Maertens, K., & Herzog, S. A. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad212 · Cited by 8
“…with a tetanus, diphthe-ria, acellular pertussis (Tdap) vaccine during pregnancy increases the titer of disease-specific antibodies in the pregnant woman, which are then transferred across the placenta to the unborn child offering protection against pertussis in the first weeks of life [7].”
BackgroundHow to improve pertussis vaccination in pregnancy: a European expert review
Finn, A. H. R., Guiso, N., von König, C. H. W., Martinón‐Torres, F., PALMU, A. A. I., Bonanni, P., Bakhache, P., Maltezou, H. C., & Damme, P. V. (2025) · Expert Review of Vaccines · doi:10.1080/14760584.2025.2473328 · Cited by 8
“Pertussis vaccination in pregnancy is >90% effective in preventing pertussis hospitalizations and even higher in preventing pertussis deaths amongst infants 2–3 months of age [1–4].”
Causes and consequences of delayed vaccination against pertussis infection in the Russian Federation
Lomonosova, A. V. (2020) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2020-97-5-11 · Cited by 9
Brousseau, N., Gagnon, D., Vivion, M., Poliquin, V., Boucoiran, I., Tapiéro, B., & Dubé, È. (2018) · CMAJ Open · doi:10.9778/cmajo.20180040 · Cited by 8
“%] v. 3 [5”
BackgroundMaternal tetanus, diphtheria, and acellular pertussis (Tdap) and influenza immunization: an overview
Brillo, E., Tosto, V., Giardina, I., & Buonomo, E. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1680633 · Cited by 10
“Furthermore, maternal immunization seems to be efficacy also to prevent early infant mortality [118,132].”
BackgroundPertussis Disease and Antenatal Vaccine Effectiveness in Australian Children
Quinn, H. E., Comeau, J. L., Marshall, H. S., Elliott, E. J., Crawford, N. W., Blyth, C. C., Kynaston, J. A., Snelling, T., Richmond, P., Francis, J. R., et al. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003367 · Cited by 9
“Recent studies from the United States have used a network of routine surveillance sites to examine severe pertussis across a wide age range, but in the context of relatively low antenatal immunization coverage, while England has used coded hospitalizations and a laboratory surveillance network to examined the impact o…”
BackgroundKuznetsova, A., Ceregido, M. A., Jourquin, A., Cámpora, L., & Silva, F. T. D. (2022) · Vaccine · doi:10.1016/j.vaccine.2021.12.050 · Cited by 8
Febriani, Y., Mansour, T., Sadarangani, M., Ulanova, M., Amaral, K., Halperin, S. A., Serres, G. D., Racine, É., & Brousseau, N. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.09.063 · Cited by 7
Antibody in Breastmilk Following Pertussis Vaccination in Three-time Windows in Pregnancy
Daniel, O., Loughnan, M., Quenby, M., Chawla, K., Greening, V., Heath, P. T., Jones, C. E., Khalil, A. A., Ramkhelawon, L., Calvert, A., et al. (2025) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004696 · Cited by 7
Janagaraj, P. D., Gurusamy, P. S. R., & Webby, R. (2018) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12896 · Cited by 8
Pertussis seronegativity in pregnant women in the city of Al Ain, United Arab Emirates
Narchı, H., Osman, W., George, J. A., Almekhaini, L. A., Souid, A., & Alsuwaidi, A. R. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.08.031 · Cited by 7
Giles, M., Gunatilaka, A., Cole, S. R., & Kollmann, T. R. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14795 · Cited by 7
Calendario de vacunaciones de la Asociación Española de Pediatría (CAV-AEP): recomendaciones 2018
Moreno‐Pérez, D., García, F. J. Á., Aldeán, J. Á., Ortega, M. J. C., Garcés‐Sánchez, M., Sánchez, N. G., Merino, Á. H., Hernández, M. J. M., Moína, M. M., Melián, A. M., et al. (2018) · Anales de Pediatría · doi:10.1016/j.anpedi.2017.10.001 · Cited by 9
Abu-Raya, B. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa831 · Cited by 7
Use of acellular pertussis vaccines in the United States: can we do better?
Klein, N. P., & Zerbo, O. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1393334 · Cited by 6
“We reported that risk for pertussis increased by 42% every year after the fifth dose of DTaP administered between ages 4 and 6 years [12].”
BackgroundInfluentialImmink, M. M., van Zoonen, K., Jager, N. M., Pluijmaekers, A. J. M., de Melker, H. E., van der Maas, N., & Bekker, M. N. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09274-1 · Cited by 6
Cheuvart, B., Callegaro, A., Rosillon, D., Meyer, N., & Guignard, A. P. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.07.057 · Cited by 6
Clark, L. R., & Johnson, D. R. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00847-5 · Cited by 7
“1), 5 publications [26, 27, 35, 36, 37] reported effectiveness (Table 1), 18 publications reported immunogenicity (Table 2) [24, 25, 38–53], 24 publications reported safety of Adacel or Adacel-Polio (Table 3) [24, 25, 40, 46, 53–72], and 7 publications reported safety of unspecified Tdap (Table 4) [73–79].”
BackgroundMethodResultInfluentialUptake of pertussis immunization in pregnancy and determinants of vaccination in Toronto, Canada
Wright, J., Science, M. E., Osman, S., Arnold, C., Sumaida, M., Crowcroft, N. S., Deeks, S. L., Brown, K. A., Halperin, S. A., Hatchette, T. F., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.10.020 · Cited by 6
Incidence and severity of pertussis among hospitalized infants, Sarawak, Malaysia, 2015-2021
Mohan, A., Tan, Y.-Y., Hashim, R., Ng, D. C.-E., Wong, V. H.-S., Liew, D.-W., Chien, S.-L., Tan, L.-S., Lau, P. S.-T., Rajandran, T., et al. (2024) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.18837 · Cited by 6
“In the United Kingdom, the vaccine effectiveness of the maternal pertussis immunization programme against infant deaths was estimated to be 95% [26].”
BackgroundSaso, A., & Kampmann, B. (2025) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004692 · Cited by 6
“48,49 However, a recent comprehensive meta-analysis and modeling study by Briga et al 50 has argued that current epidemiological data may under-estimate the long-term impact of blunting because of “transient dynamics,” that is, the immediate protective benefits of maternal antibodies in…”
Gaillard, M. E., Bottero, D., Zurita, M. E., Carriquiriborde, F., Aispuro, P. M., Bartel, E., Martínez, D., Bravo, M. S., Castuma, C. E., & Hozbor, D. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01099 · Cited by 6
“A further report in England related the key observation that vaccine effectiveness against laboratory-confirmed pertussis had been sustained during the 3 years following the vaccine’s introduction in 2012 (18).”
BackgroundResultInfluentialLow levels of detectable pertussis antibody among a large cohort of pregnant women in Canada
Brooks, J., Bell, C. A., Rotondo, J., Gilbert, N. L., Tunis, M. C., Ward, B. J., & Desai, S. N. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.066 · Cited by 6
Heininger, U. (2020) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-020-00941-9 · Cited by 6
Improving Tdap maternal immunization rate in Saudi Arabia
Aldoosari, A., Alosaimi, B., & Khalaf, M. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2253585 · Cited by 5
Co-administration of vaccines in pregnancy: unique challenges and knowledge gaps
Abu-Raya, B., Giles, M., & Kollmann, T. R. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127309 · Cited by 5
Maternal vaccination to prevent neonatal infections and combat antimicrobial resistance
Galiza, E. P., Nakebembe, E., Mboizi, R. B., Okek, E. J., & Doaré, K. L. (2025) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2025.101680 · Cited by 5
Amin, R., Ronald Darwin, C., Sarma, M. K., Herrera‐Bravo, J., Sharifi‐Rad, J., & Călina, D. C. (2026) · Journal of Health Population and Nutrition · doi:10.1186/s41043-026-01270-5 · Cited by 5
Immunisation schedule of the Spanish Association of Paediatrics: 2018 recommendations
Moreno‐Pérez, D., García, F. J. Á., Aldeán, J. Á., Ortega, M. J. C., Garcés‐Sánchez, M., Sánchez, N. G., Merino, Á. H., Hernández, M. J. M., Moína, M. M., Melián, A. M., et al. (2018) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2017.11.001 · Cited by 5
“(7) Measles, mumps and rubella vaccine (MMR).”
Edwards, K. M., Decker, M. D., & Damron, F. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00045-1 · Cited by 6
Röbl-Mathieu, M., & Terhardt, M. (2021) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-021-01321-7 · Cited by 5
Galiza, E. P., Calvert, A., Drysdale, S. B., & Heath, P. T. (2021) · Medicine · doi:10.1016/j.mpmed.2021.09.002 · Cited by 5
Maertens, K., Leuridan, E. E., Muñoz, F. M., Zimmermann, P., Curtis, N. C., Halperin, S. A., Rots, N. Y., Barug, D., Holder, B. S., Sadarangani, M., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.06.045 · Cited by 5
“For pertussis for example, current evidence does not suggest that infants born to women vaccinated against pertussis during pregnancy have higher risk for pertussis later in their infancy compared to infants of unvaccinated women [9].”
BackgroundEffectiveness of maternal pertussis vaccination in Singapore: A test-negative case-control study
Chong, C.-Y., Tan, N. W., Yung, C.-F., Li, J., Kam, K., Nadua, K. D., Maiwald, M., Sultana, R., & Thoon, K. C. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.09.087 · Cited by 5
Metadata
- Authors
- Amirthalingam, G., Campbell, H., Ribeiro, S., Fry, N. K., Ramsay, M., Miller, E., & Andrews, N.
- Affiliations
- Public Health England (GB)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-12
- Volume
- 63
- Issue
- suppl 4
- Pages
- S236-S243
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5106626
- OpenAlex
- W2554060857
- Cited by
- 275
- References
- 20
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 10 · 2023: 23 · 2022: 21 · 2021: 54 · 2020: 38 · 2019: 34 · 2018: 39 · 2017: 26
- FWCI
- 33.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Funders
- Public Health England
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Diphtheria, Corynebacterium, and Tetanus
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- acellular pertussis vaccine, vaccine effectiveness, infant pertussis prevention, infant mortality, vaccine safety, disease incidence, England
- MeSH terms
- Adult, England, Female, Humans, Immunization Schedule, Infant, Infant, Newborn, Male, Mortality, Population Surveillance, Vaccination, Whooping Cough, Diphtheria-Tetanus-Pertussis Vaccine, Incidence, Outcome Assessment, Health Care, Immunization Programs, Maternal Exposure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.